NCT01640080View on ClinicalTrials.gov

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 27, 2012

Primary Completion Date

June 3, 2013

Study Completion Date

June 3, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

Esketamine

Type= exact number, number= 0.20, unit= mg/kg, form= intravenous infusion, route= intravenous use. One single intravenous infusion of esketamine 0.20 mg/kg administered on Day 1 and Day 4.

DRUG

Esketamine

Type= exact number, number= 0.40, unit= mg/kg, form= intravenous infusion, route= intravenous use. One single intravenous infusion of esketamine 0.40 mg/kg administered on Day 1 and Day 4.

DRUG

Placebo

Form= intravenous infusion, route= intravenous use. One single placebo intravenous infusion administered on Day 1 and Day 4.

Trial Locations (9)

Unknown

Dave

Ghent

Kortenberg

Lede

Berlin

Freiburg im Breisgau

Mainz

München

Gdansk

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01640080 - A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter